Nouscom
Clinical-stage biotech developing neoantigen-based cancer immunotherapies.
€120MSeries D
ParticipantActivity from announced rounds
Clinical-stage biotech developing neoantigen-based cancer immunotherapies.
RNA therapeutics designed to restore expression of silenced genes
Clastix builds Kubernetes infrastructure software, including Kamaji for hosted tenant control planes and kMetal for bare-metal cluster operations.
Tundr gives employers a digital employee-benefits program built around a Mastercard for fringe benefits, a flexible-benefits app for employees and a management console for HR teams.